Durect Corp (DRRX) Stock Price, Quote & News

Company Profile

DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company's lead product candidate includes larsucosterol, an endogenous, orally bioavailable small molecule to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as for the treatment of patients with metabolic dysfunction-associated steatohepatitis. The company also offers POSIMIR,...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 408 777 1417

Fax: 408 777 3577

Website: www.durect.com

Address:

10240 Bubb Road, Cupertino, United States

Joby099 Aug. 2 at 1:38 AM

$DRRX

0 · Reply

Godwins26 Aug. 1 at 3:26 PM

$DRRX another one $ATCH

0 · Reply

kdsyy Aug. 1 at 2:20 PM

$DRRX This wave of growth is like riding a rocket 🚀, it is really unexpected! I have to say that those who can catch it in advance have a great vision. For example, I

0 · Reply

CumulativeChaser Aug. 1 at 6:25 AM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $VWAV $DRRX $VAPE $MCVT $CELC

0 · Reply

Joby099 Aug. 1 at 1:15 AM

$DRRX

0 · Reply

Travelling Jul. 31 at 5:10 PM

$NEGG OK sold the last. I shall watch closely for dips. Also watching $AACG $SMX $DRRX $SNDL

1 · Reply

Drrxgernbcrx Jul. 31 at 12:33 AM

$DRRX I wish I could read and understand legal language better. Is the 8k saying 50% of stockholder must accept the 1.75 proposal for it go go thru OR that more than 50% must take no action AGAINST the offer

1 · Reply

davis8uni Jul. 30 at 10:15 PM

$DRRX I like the explanation of catalysts here. He is killing it. Must watch! https://www.youtube.com/watch?v=ZeJ3k2WD3Sw

1 · Reply

Godwins26 Jul. 30 at 8:16 PM

I'm watching these 2 closely $DRRX this has been holding gains for a while stronger bulls holding this 😊 $REPL keep up the good work 😁

0 · Reply

Godwins26 Jul. 30 at 6:16 PM

$DRRX only because it needs more push that's all 😊

0 · Reply

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout

BHC

Jul 29, 2025, 7:00 AM EDT - 3 days ago

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease

BHC

May 13, 2025, 4:05 PM EDT - 2 months ago

DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update

Mar 26, 2025, 8:04 PM EDT - 4 months ago

DURECT Corporation (DRRX) Q4 2024 Earnings Call Transcript

Mar 26, 2025, 4:05 PM EDT - 4 months ago

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 19, 2025, 4:30 PM EDT - 4 months ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

Feb 4, 2025, 7:30 AM EST - 6 months ago

DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference

Jan 28, 2025, 10:09 AM EST - 6 months ago

DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence

Nov 25, 2024, 6:00 AM EST - 8 months ago

DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million

Nov 13, 2024, 10:17 PM EST - 9 months ago

DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 4:01 PM EST - 9 months ago

DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 6, 2024, 4:45 PM EST - 9 months ago

DURECT Corporation to Announce Third Quarter 2024 Financial Results and Provide a Business Update

Oct 17, 2024, 8:30 AM EDT - 10 months ago

DURECT Corporation to Present Data on Larsucosterol at The Liver Meeting 2024

Sep 25, 2024, 8:00 AM EDT - 11 months ago

DURECT Corporation Announces Phase 3 Registrational Trial Design for Larsucosterol in Alcohol-associated Hepatitis

Sep 4, 2024, 4:30 PM EDT - 11 months ago

DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference

Aug 13, 2024, 8:42 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 4:01 PM EDT - 1 year ago

DURECT Corporation Reports Second Quarter 2024 Financial Results and Business Update

Aug 7, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce Second Quarter 2024 Financial Results and Provide a Business Update

May 21, 2024, 8:00 AM EDT - 1 year ago

DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

May 13, 2024, 9:54 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 1 year ago

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update

May 7, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update

Apr 30, 2024, 7:00 AM EDT - 1 year ago

DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis

Mar 27, 2024, 6:07 PM EDT - 1 year ago

DURECT Corporation (DRRX) Q4 2023 Earnings Call Transcript

Mar 27, 2024, 4:01 PM EDT - 1 year ago

DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Mar 20, 2024, 4:30 PM EDT - 1 year ago

DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update

Mar 4, 2024, 7:00 AM EST - 1 year ago

DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada

Feb 7, 2024, 6:48 PM EST - 1 year ago

DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Dec 18, 2023, 7:39 AM EST - 1 year ago

Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)

Nov 13, 2023, 6:50 PM EST - 1 year ago

DURECT Corporation (DRRX) Q3 2023 Earnings Call Transcript

Nov 13, 2023, 4:05 PM EST - 1 year ago

DURECT Corporation Reports Third Quarter 2023 Financial Results and Business Update

Nov 9, 2023, 4:30 PM EST - 1 year ago

DURECT Corporation to Announce Third Quarter 2023 Financial Results and Provide a Business Update

Nov 7, 2023, 4:01 PM EST - 1 year ago

DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality

Sep 7, 2023, 7:00 AM EDT - 2 years ago

DURECT Corporation Announces Last Patient Last Visit in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis

Aug 31, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation Announces Presentations in Upcoming Investor Conferences

Aug 9, 2023, 8:22 PM EDT - 2 years ago

DURECT Corporation (DRRX) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 4:05 PM EDT - 2 years ago

DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update

Aug 3, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation to Announce Second Quarter 2023 Financial Results and Provide a Business Update

Jul 20, 2023, 8:00 AM EDT - 2 years ago

DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Jun 7, 2023, 6:00 AM EDT - 2 years ago

DURECT Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis

May 8, 2023, 10:42 PM EDT - 2 years ago

DURECT Corporation (DRRX) Q1 2023 Earnings Call Transcript

May 8, 2023, 4:05 PM EDT - 2 years ago

DURECT Corporation Reports First Quarter 2023 Financial Results and Business Update

May 1, 2023, 7:03 PM EDT - 2 years ago

DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8

Apr 27, 2023, 5:11 PM EDT - 2 years ago

DURECT Corporation to Host KOL Event on Alcohol-Associated Hepatitis

Apr 25, 2023, 6:45 PM EDT - 2 years ago

DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference

Apr 10, 2023, 6:00 AM EDT - 2 years ago

DURECT Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2a Study of Larsucosterol in Alcohol-Associated Hepatitis

Mar 21, 2023, 4:30 PM EDT - 2 years ago

DURECT Corporation Announces Appointment of Gail Maderis as Chair of the Board

Mar 9, 2023, 8:30 AM EST - 2 years ago

DURECT Corporation Fireside Chat at the Oppenheimer 33rd Annual Healthcare Conference

Joby099 Aug. 2 at 1:38 AM

$DRRX

0 · Reply

Godwins26 Aug. 1 at 3:26 PM

$DRRX another one $ATCH

0 · Reply

kdsyy Aug. 1 at 2:20 PM

$DRRX This wave of growth is like riding a rocket 🚀, it is really unexpected! I have to say that those who can catch it in advance have a great vision. For example, I

0 · Reply

CumulativeChaser Aug. 1 at 6:25 AM

Caught a few of @CarlosRivera_’s plays recently dude’s been on point! If you're into trading, he's worth a follow💯 watchlist: $VWAV $DRRX $VAPE $MCVT $CELC

0 · Reply

Joby099 Aug. 1 at 1:15 AM

$DRRX

0 · Reply

Travelling Jul. 31 at 5:10 PM

$NEGG OK sold the last. I shall watch closely for dips. Also watching $AACG $SMX $DRRX $SNDL

1 · Reply

Drrxgernbcrx Jul. 31 at 12:33 AM

1 · Reply

davis8uni Jul. 30 at 10:15 PM

$DRRX I like the explanation of catalysts here. He is killing it. Must watch! https://www.youtube.com/watch?v=ZeJ3k2WD3Sw

1 · Reply

Godwins26 Jul. 30 at 8:16 PM

I'm watching these 2 closely $DRRX this has been holding gains for a while stronger bulls holding this 😊 $REPL keep up the good work 😁

0 · Reply

Godwins26 Jul. 30 at 6:16 PM

$DRRX only because it needs more push that's all 😊

0 · Reply

Seekthegain Jul. 30 at 5:07 PM

$DRRX will the company remain a separate entity under the Bausch umbrella? If so, I'm buying a soon to be phase 3 company for $.15. I need clarification the milestone payment would feed back into the company hence my pocket. If so this looks very cheap with very little downside

1 · Reply

WEDIDITJOE Jul. 30 at 4:59 PM

$DRRX why is this thing only moving a penny up and down?

1 · Reply

Stockermania Jul. 30 at 3:29 PM

$VWAV $OPEN $DRRX $LIDR I mentioned about reversal yesterday and VWAV went to 11.80 from 6.87 open today.. Stock had a pull back and is currently at $8.50 Great loading zone again for a run to $12-$15+ today low floater.. Bullish

0 · Reply

Godwins26 Jul. 30 at 2:34 PM

Watch these too today 😊🤝 $DRRX went up over 250% yesterday $FTAI

0 · Reply

Godwins26 Jul. 30 at 2:25 PM

Watchlist today 🤑 🚀 $DRRX $XBP $SUPX $REPL

1 · Reply

Joby099 Jul. 30 at 12:22 PM

$DRRX

2 · Reply

DMONEY1337 Jul. 30 at 11:56 AM

$DRRX

1 · Reply

Joby099 Jul. 30 at 8:30 AM

$DRRX Nice breakdown of important datas. This dude know his thing. Must watch! https://www.youtube.com/watch?v=ZeJ3k2WD3Sw

1 · Reply

Amjad1_ Jul. 30 at 5:31 AM

$DRRX

0 · Reply

msufans Jul. 30 at 1:31 AM

$DRRX finally!! At this price, im still losing money, but at this price, at least i will get my money back 70%. That's a guarantee. I will wait until the EOY. Regardless I'm happy

0 · Reply

StockScanners Jul. 30 at 12:56 AM

$DRRX Keep watch if this holds above 1.75

0 · Reply

Godwins26 Jul. 29 at 10:59 PM

$DRRX the support so strong we can't go nowhere but up

0 · Reply

Market Cap	58.05M
Revenue (ttm)	2.03M
Net Income (ttm)	-8.32M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-409.85%
Debt to Equity Ratio	0.00

Volume	862,500
Avg Vol	1,154,126
Day's Range	N/A - N/A
Shares Out	31.04M
Stochastic %K	62%
Beta	0.64
Analysts	Strong Sell
Price Target	$2.50